Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia-Reference-Cited by-同舟云学术

Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia

Published:2014-10-21 Issue:9 Volume:20 Page:1091-1100
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Banerjee A,Wang H-Y,Borgmann-Winter K E,MacDonald M L,Kaprielian H,Stucky A,Kvasic J,Egbujo C,Ray R,Talbot K,Hemby S E,Siegel S J,Arnold S E,Sleiman P,Chang X,Hakonarson H,Gur R E,Hahn C-G

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

http://www.nature.com/articles/mp2014115.pdf

Reference65 articles.

1. Coyle JT . Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006; 26: 365–384.

2. Javitt DC, Schoepp D, Kalivas PW, Volkow ND, Zarate C, Merchant K et al. Translating glutamate: from pathophysiology to treatment. Sci Transl Med 2011; 3: 102mr102.

3. Moghaddam B, Javitt D . From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 2012; 37: 4–15.

4. Farber NB . The NMDA receptor hypofunction model of psychosis. Ann NY Acad Sci 2003; 1003: 119–130.

5. Javitt DC, Zukin SR . Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991; 148: 1301–1308.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blocking Src-PSD-95 interaction rescues glutamatergic signaling dysregulation in schizophrenia;2024-03-08

2. Epigenetic profile of the immune system associated with symptom severity and treatment response in schizophrenia;Journal of Psychiatry and Neuroscience;2024-02-15

3. Proteomic Characteristics of the Prefrontal Cortex and Hippocampus in Mice with Chronic Ketamine-Induced Anxiety and Cognitive Impairment;Neuroscience;2024-01

4. DNA methylation and the opposing NMDAR dysfunction in schizophrenia and major depression disorders: a converging model for the therapeutic effects of psychedelic compounds in the treatment of psychiatric illness;Molecular Psychiatry;2023-09-07

5. Network Toxicology and Molecular Docking to Investigate the Non-AChE Mechanisms of Organophosphate-Induced Neurodevelopmental Toxicity;Toxics;2023-08-17